EUVIMEDEUVIMED entdecken
Systematische ÜbersichtOpen Access · CC BY 4.0

From Genotype to Phenotype: Investigating SLC22A5 Variants and Their Significance in Carnitine Deficiency: A Systematic Review Study

Amir Ghaffari Jolfayi, Mahdieh Soveizi, Niloofar Naderi, Amirali Soheili, Maryam Pourirahim, Leyla Abdolkarimi, Majid Maleki, Samira Kalayinia iD

Journal of Cellular and Molecular Medicine · 2026-07 · 30 (14)

DOI: 10.1111/jcmm.71273 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Journal of Cellular and Molecular Medicine, online erschienen am 21.07.2026. Verfasst von Amir Ghaffari Jolfayi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Cardiovascular Research Center, Rajaie Cardiovascular Institute, Tehran, Iran. Hauptthemen laut MEDLINE: Solute Carrier Family 22 Member 5, Carnitine, Muscular Diseases, Hyperammonemia. Die Arbeit nennt 145 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Primary carnitine deficiency (PCD) is an autosomal recessive disorder caused by mutations in the SLC22A5 gene, which encodes the organic cation transporter 2 (OCTN2). These mutations impair carnitine transport and fatty acid metabolism, leading to a wide range of clinical symptoms, from mild fatigue to severe cardiomyopathy. Although over 100 mutations have been identified, the correlation between specific genotypes and pathogenicity remains unclear, necessitating further investigation into their molecular and clinical impacts. This systematic review aims to evaluate the association between SLC22A5 mutations and PCD, with a focus on cardiomyopathy, to characterise the molecular and functional consequences of these variants, and to explore their implications for diagnosis, treatment, and personalised care. A systematic search of PubMed was conducted, focusing on studies reporting genetic, clinical, and biochemical data related to SLC22A5. Variants were classified according to ACMG guidelines and CADD scoring, and the data were synthesised through descriptive analyses. Most reported variants are missense mutations, accounting for approximately 80% of cases, followed by deletions (12.7%), while duplications, insertions, and deletion–insertion variants are rare. According to ACMG classification, the majority of variants are pathogenic or likely pathogenic (≈72%), with VUS comprising about 24%, and benign variants being uncommon. Exons 1 and 8 have the highest frequencies, whereas Exons 5 and 6, despite fewer variants, exhibit higher mean CADD scores, suggesting greater functional impact. The findings revealed that Exons 1 and 8 harboured the most frequent mutations, while Exons 5 and 6 showed the highest pathogenicity. Nonsense variants exhibit the highest pathogenicity and CADD scores, followed by frameshift and missense mutations. Severe truncating mutations were linked to early‐onset cardiomyopathy. Intronic variants are infrequent but include sites with high CADD scores, indicating potential regulatory relevance. Overall, these findings demonstrate that variant pathogenicity is influenced more by functional impact than by frequency alone.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Solute Carrier Family 22 Member 5CarnitineMuscular DiseasesHyperammonemiaMutationCardiomyopathiesGenetic Association StudiesGenetic Predisposition to DiseaseHumansPhenotypeGenotype

Stichwörter der Autor:innen

OCTN2SLC22A5cardiomyopathymutationprimary carnitine deficiency

Substanzen

Solute Carrier Family 22 Member 5SLC22A5 protein, humanCarnitine

Autor:innen und Institutionen

  • Cardiovascular Research Center, Rajaie Cardiovascular Institute, Tehran, Iran.
  • Cardiogenetic Research Center, Rajaie Cardiovascular Institute, Tehran, Iran.

ORCID-Profile: Samira Kalayinia

Zitieren

APA

Ghaffari Jolfayi, A., Soveizi, M., Naderi, N., Soheili, A., Pourirahim, M., Abdolkarimi, L., Maleki, M., & Kalayinia, S. (2026). From Genotype to Phenotype: Investigating SLC22A5 Variants and Their Significance in Carnitine Deficiency: A Systematic Review Study. Journal of Cellular and Molecular Medicine, 30(14). https://doi.org/10.1111/jcmm.71273

Vancouver

Ghaffari Jolfayi A, Soveizi M, Naderi N, Soheili A, Pourirahim M, Abdolkarimi L, et al. From Genotype to Phenotype: Investigating SLC22A5 Variants and Their Significance in Carnitine Deficiency: A Systematic Review Study. Journal of Cellular and Molecular Medicine. 2026;30(14). doi:10.1111/jcmm.71273

BibTeX
@article{GhaffariJolfayi2026,
  author = {Ghaffari Jolfayi, Amir and Soveizi, Mahdieh and Naderi, Niloofar and Soheili, Amirali and Pourirahim, Maryam and Abdolkarimi, Leyla and Maleki, Majid and Kalayinia, Samira},
  title = {From Genotype to Phenotype: Investigating SLC22A5 Variants and Their Significance in Carnitine Deficiency: A Systematic Review Study},
  journal = {Journal of Cellular and Molecular Medicine},
  year = {2026},
  volume = {30},
  number = {14},
  doi = {10.1111/jcmm.71273}
}
Kostenlos starten →